98516-80-4

Basic information

• Product Name: ethyl 2-formyl-3-phenylpropionate
• CAS NO: 98516-80-4
• Molecular Weight: 206.241
• Mol File: 98516-80-4.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: ethyl 2-formyl-3-phenylpropionate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-formyl-3-phenylpropionate(98516-80-4)
• EPA Substance Registry System: ethyl 2-formyl-3-phenylpropionate(98516-80-4)

Safety Data

• Hazardous Substances Data: 98516-80-4(Hazardous Substances Data)

Upstream product

• 6731-58-4 ethyl 2-cyano-3-phenylpropanoate 
• 2025-40-3 ethyl benzylidenecyanoacetate 
• 64-17-5 ethanol 
• 7732-18-5 water 
• 141-78-6 ethyl acetate 
• 107-31-3 Methyl formate 
• 2021-28-5 ethyl dihydrocinnamate 
• 901788-34-9 2-Benzyl-N-methoxy-N-methyl-malonamic acid ethyl ester 
• 107749-65-5 ethyl α-(hydroxymethyl)benzenepropanoate 
• 100-44-7 benzyl chloride 
• 18852-51-2 sodium cyanoacetic acid ethyl ester 
• 623-47-2 propynoic acid ethyl ester 
• 81239-00-1 ethyl (E)-3-(piperidin-1-yl)acrylate 
• 100-39-0 benzyl bromide 

Downstream Products

• 97440-53-4 (2Ξ,4R)-2-((Ξ)-1-ethoxycarbonyl-2-phenyl-ethyl)-thiazolidine-4-carboxylic acid 
• 873409-32-6 2-amino-5-benzylpyrimidin-4(3H)-one 
• 104-53-0 3-phenyl-propionaldehyde 
• 501-52-0 3-Phenylpropionic acid 
• 41712-14-5 indene-2-carboxylic acid 
• 106167-47-9 1H-indene-2-carboxylic acid ethyl ester 
• 607714-55-6 2-(benzyloxyimino-methyl)-3-phenyl-propionic acid ethyl ester 
• 62247-36-3 ethyl 2-benzyl-3-methoximinopropionate 
• 18493-83-9 5-benzyluracil 

Relevant articles and documents

PYRAZOLOPYRIMIDINE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME

The present disclosure is directed to pyrazolo[1,5-a]pyrimidine compounds of formula (I), pharmaceutical compositions thereof and methods for modulating or activating a Parkin ligase The present disclosure is also directed to methods of treating and/or reducing the incidence of diseases or conditions related to the activation of Parkin ligase. R21, R22, R23, R24 and R25 are as defined herein.

Lewis base catalyzed asymmetric hydrosilylation of α-substituted β-enamino esters: Facile access to enantioenriched β2-amino esters via dynamic kinetic resolution

A chiral Lewis base organocatalyzed asymmetric hydrosilylation of α-substituted β-enamino esters is presented. The reactions proceeded through dynamic kinetic resolution to afford various enantioenriched β2-amino esters with high yields (up to

NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun